亚洲一区二区三区中文字幂,在线观看免费人成视频色9,最近最新高清中文字幕,阳茎伸入阳道全过程视频,中出老熟女中文字幕

Your Good Partner in Biology Research

  1. Home
  2. 抗體
  3. 重組抗體
  4. GUCY2C Recombinant Monoclonal Antibody

GUCY2C Recombinant Monoclonal Antibody

  • 中文名稱：
    GUCY2C重組抗體
  • 貨號：
    CSB-RA010053A3HU
  • 規(guī)格：
    ￥1320
  • 圖片：
    • The Binding Activity of Human GUCY2C with Anti-GUCY2C recombinant antibody
      Activity: Measured by its binding ability in a functional ELISA. Immobilized Human GUCY2C (CSB-MP010053HU) at 5 μg/mL can bind Anti-GUCY2C recombinant antibody, the EC50 is 5.630-9.996 ng/mL.
    • T84 cells were stained with Human IgG (green line) and anti-GUCY2C antibody (red line) (2μg/1*106cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.
    • Untransfected CT26 cells surface (green line) and transfected Human GUCY2C CT26 stable cells surface (red line) were stained with anti-GUCY2C antibody (2μg/1*106cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.
  • 其他：

產(chǎn)品詳情

  • 產(chǎn)品描述：
    CSB-RA010053A3HU GUCY2C重組單克隆抗體是針對鳥苷酸環(huán)化酶C受體（GUCY2C）開發(fā)的高特異性科研試劑，適用于酶聯(lián)免疫吸附（ELISA）和流式細胞術(shù)（FC）檢測。該抗體靶向GUCY2C蛋白胞外結(jié)構(gòu)域，經(jīng)免疫印跡驗證顯示其能特異性識別天然構(gòu)象的靶標蛋白。在流式細胞分析中，該抗體在1:50至1:200稀釋范圍內(nèi)展現(xiàn)穩(wěn)定的檢測性能，適用于細胞表面受體表達的定量分析。GUCY2C作為調(diào)控腸道離子平衡和細胞增殖的關(guān)鍵跨膜受體，其異常表達與結(jié)直腸上皮病變密切相關(guān)，本產(chǎn)品可為結(jié)直腸癌相關(guān)細胞信號通路研究、腫瘤標志物篩選及體外模型構(gòu)建提供可靠工具。該抗體采用哺乳動物表達系統(tǒng)制備，具有高批次間一致性，建議配合同源二抗使用以獲得最優(yōu)檢測效果，適用于細胞樣本的表面標記檢測及蛋白互作研究等基礎科研領域。
  • Uniprot No.：
  • 基因名：
  • 別名：
    GC-C antibody; Guanylyl cyclase C antibody; GUC2C antibody; GUC2C_HUMAN antibody; GUCY2C antibody; Heat stable enterotoxin receptor antibody; Heat-stable enterotoxin receptor antibody; hSTAR antibody; Intestinal guanylate cyclase antibody; STA receptor antibody
  • 反應種屬：
    Human
  • 免疫原：
    Recombinant Human GUCY2C protein
  • 免疫原種屬：
    Homo sapiens (Human)
  • 標記方式：
    Non-conjugated
  • 克隆類型：
    Monoclonal
  • 抗體亞型：
    hIgG1
  • 純化方式：
    Affinity-chromatography
  • 克隆號：
    2E5
  • 濃度：
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液：
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
  • 產(chǎn)品提供形式：
    Liquid
  • 應用范圍：
    ELISA, FC
  • 推薦稀釋比：
    Application Recommended Dilution
    FC 1:50-1:200
  • Protocols：
  • 儲存條件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期：
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途：
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點詳情

  • 功能：
    Receptor for the E.coli heat-stable enterotoxin (E.coli enterotoxin markedly stimulates the accumulation of cGMP in mammalian cells expressing GC-C). Also activated by the endogenous peptides guanylin and uroguanylin.
  • 基因功能參考文獻：
    1. High Expressions of guanylyl cyclase C is associated with rectal cancer. PMID: 28418917
    2. The findings support that the activating mutation in GUCY2C creates an intestinal environment with a major influence on the microbiota, which could contribute to the increased susceptibility to inflammatory bowel disease in patients with Familial GUCY2C diarrhea syndrome. PMID: 28902124
    3. the expression of GCC is maintained throughout the process of tumor progression and formation of metastatic disease. PMID: 29261789
    4. To investigate gut motility and hormones before and after a meal in Familial GUCY2C diarrhea syndrome patients and compare with healthy controls PMID: 28957388
    5. Mutations in GUCY2C indicate a role for this receptor in the pathogenesis of sporadic Congenital secretory diarrhea. PMID: 25994218
    6. these data support Ad5-GUCY2C-PADRE as a safe and effective vaccination strategy in preclinical models and position Ad5-GUCY2C-PADRE for Phase I clinical testing in colorectal cancer patients. PMID: 27903079
    7. Familial GUCY2C diarrhoea syndrome is caused by an activating mutation in the GUCY2C gene, which causes impaired contractility and fluid stagnation in the small bowel PMID: 27338166
    8. Findings show how caloric suppression of the guanylin-GUCY2C signaling axis links obesity to negation of a universal tumor suppressor pathway in colorectal cancer. PMID: 26773096
    9. Data show that individuals affected with meconium ileus (MI) had either homozygous or compound heterozygous variants in enterotoxin receptor GUCY2C. PMID: 25370039
    10. High guanylyl cyclase C expression is associated with colon cancer recurrence. PMID: 24919572
    11. Transmission disequilibrium tests (TDT), case-control studies and quantitative analyses indicated association between GUC2C with Attention-deficit/hyperactivitydisorder and its core symptoms. PMID: 25064385
    12. Intestinal cell proliferation and senescence are regulated by receptor guanylyl cyclase C and p21. PMID: 24217248
    13. GUCY2C signaling constitutes a direct link between the initiation of colorectal cancer and the induction of its associated desmoplastic stromal niche. PMID: 24085786
    14. Data show that lower survival (OS) and disease-free survival (DFS) rates were significantly associated with guanylate cyclase C (GCC) and CK20 mRNA levels. PMID: 23150200
    15. Interaction with VIP36 is dependent on glycosylation at the same sites that allow GC-C to fold and bind ligand. PMID: 23269669
    16. GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity PMID: 22384056
    17. Mutations in GUCY2C were associated with the Meconium ileus phenotype. downregulation of GUCY2C leads to a cystic fibrosis-like intestinal phenotype. PMID: 22521417
    18. We identified a heterozygous missense mutation (c.2519G-->T) in GUCY2C in all family members with familial diarrhea syndrome. PMID: 22436048
    19. High guanylyl cyclase C is associated with colon cancer. PMID: 21533822
    20. Data suggest that monitoring the peripheral blood GCC expressions may allow employing different treatment options to metastatic CRC patients. PMID: 21901559
    21. Lymph nodes (range: 2-159) from 291 prospectively enrolled node-negative colorectal cancer patients were analyzed by histopathology and GUCY2C quantitative RT-PCR. PMID: 21307149
    22. Longer survival was associated with hypomethylation at specific CpG sites (e.g. GREB1, TGIF and TOB1) and hypermethylation in other genes (e.g. TMCO5, PTPRN and GUCY2C). PMID: 21577013
    23. A novel PDZ protein regulates the activity of guanylyl cyclase C, the heat-stable enterotoxin receptor. PMID: 11950846
    24. guanylyl cyclase c is ectopically expressed in primary and metastatis adenocarcinoma of the esophagus and stomach PMID: 12163327
    25. SH3 domain -mediated protein-protein interaction with the catalytic domain of guanylyl cyclase C inhibited the cyclase activity and might be pivotal for the desensitization phenomenon of the guanylyl cyclase C receptor PMID: 12649275
    26. gelatinolytic activity of GCC in colorectal tumor tissues may facilitate the hepatic metastatic process in the steps after intravasation but not during or before intravasation PMID: 14581363
    27. a novel role for glycosidic modification of GC-C during its biosynthesis, in imparting subtle conformational changes in the receptor that allow for ligand-mediated activation and perhaps regulation of basal activity PMID: 14748740
    28. Lack of guanylyl cyclase c expression assoeciated with significant reduction in adenomas in Apc(Min/+);Gucy2c(-/-) mice PMID: 15825168
    29. Transformation associated with reflux at the gastroesophageal junction reflects activation by bile acid and acid of a transcriptional program involving NF-kappaB and Cdx2, which mediate intestinal metaplasia and ectopic expression of GC-C. PMID: 16618413
    30. This validated assay is being applied to approximately 10,000 lymph nodes in a prospective trial to define the sensitivity of Guanylyl cyclase C(GCC) qRT-PCR for staging patients with colorectal cancer. PMID: 16899600
    31. docking of the c-src SH2 domain to phosphorylated GC-C results in colocalization and further activation of c-src. PMID: 19620276
    32. the role of the linker region in receptor guanylyl cyclases PMID: 19648115
    33. GCC is a specific marker for differentiating primary and secondary metatstatic ovarian mucinous neoplasms. PMID: 19694825
    34. Results suggest that GUCY2C quantitative reverse transcriptase (qRT)-PCR can be used to detect occult lymph node metastases in pN0 colorectal cancer patients. PMID: 19895223
    35. Expression of the receptor guanylyl cyclase C and its ligands in reproductive tissues of the rat: a potential role for a novel signaling pathway in the epididymis. PMID: 12444076
    36. The protein kinase-like domain in receptor guanylyl cyclase C provides a critical structural link between the extracellular domain and the catalytic domain in regulation of this family of receptors. PMID: 11478887

    顯示更多

    收起更多

  • 相關(guān)疾?。?/div>
    Diarrhea 6 (DIAR6); Meconium ileus (MECIL)
  • 亞細胞定位：
    Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-pass type I membrane protein. Note=The 145 kDa plasma membrane form of GC-C contains sialic acid and galactose residues, while a differencially glycosylated 130 Kda form is a high mannose form that is resident in the endoplasmic reticulum and may serve as the precursor for the cell surface form.
  • 蛋白家族：
    Adenylyl cyclase class-4/guanylyl cyclase family
  • 數(shù)據(jù)庫鏈接：

    HGNC: 4688

    OMIM: 601330

    KEGG: hsa:2984

    STRING: 9606.ENSP00000261170

    UniGene: Hs.524278